1. Home
  2. WFRD vs CRSP Comparison

WFRD vs CRSP Comparison

Compare WFRD & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WFRD
  • CRSP
  • Stock Information
  • Founded
  • WFRD 1941
  • CRSP 2013
  • Country
  • WFRD United States
  • CRSP Switzerland
  • Employees
  • WFRD N/A
  • CRSP N/A
  • Industry
  • WFRD Metal Fabrications
  • CRSP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WFRD Industrials
  • CRSP Health Care
  • Exchange
  • WFRD Nasdaq
  • CRSP Nasdaq
  • Market Cap
  • WFRD 3.0B
  • CRSP 3.3B
  • IPO Year
  • WFRD N/A
  • CRSP 2016
  • Fundamental
  • Price
  • WFRD $43.60
  • CRSP $36.29
  • Analyst Decision
  • WFRD Strong Buy
  • CRSP Buy
  • Analyst Count
  • WFRD 7
  • CRSP 16
  • Target Price
  • WFRD $96.43
  • CRSP $73.07
  • AVG Volume (30 Days)
  • WFRD 1.1M
  • CRSP 2.1M
  • Earning Date
  • WFRD 07-22-2025
  • CRSP 05-06-2025
  • Dividend Yield
  • WFRD 2.29%
  • CRSP N/A
  • EPS Growth
  • WFRD 1.65
  • CRSP N/A
  • EPS
  • WFRD 6.29
  • CRSP N/A
  • Revenue
  • WFRD $5,348,000,000.00
  • CRSP $37,675,000.00
  • Revenue This Year
  • WFRD N/A
  • CRSP $26.79
  • Revenue Next Year
  • WFRD $3.58
  • CRSP $297.32
  • P/E Ratio
  • WFRD $6.93
  • CRSP N/A
  • Revenue Growth
  • WFRD 0.77
  • CRSP N/A
  • 52 Week Low
  • WFRD $36.74
  • CRSP $30.04
  • 52 Week High
  • WFRD $135.00
  • CRSP $67.88
  • Technical
  • Relative Strength Index (RSI)
  • WFRD 41.50
  • CRSP 46.12
  • Support Level
  • WFRD $44.17
  • CRSP $35.38
  • Resistance Level
  • WFRD $46.82
  • CRSP $38.13
  • Average True Range (ATR)
  • WFRD 1.51
  • CRSP 1.73
  • MACD
  • WFRD -0.20
  • CRSP -0.03
  • Stochastic Oscillator
  • WFRD 0.79
  • CRSP 26.30

About WFRD Weatherford International plc

Weatherford International provides diversified oilfield services across international markets for an array of oilfield types. The firm is a global market leader in artificial lift and tubular running services. Other key product lines include cementing products, directional drilling, and wireline evaluation.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: